sample_name	a260_280	barcode	center_name	center_project_name	dna_concentration	experiment_design_description	flowcells	gear57	instrument_model	library_construction_protocol	linker	number_reads	pcr_primers	platform	primer	qiita_prep_id	run_center	run_date	run_prefix	sequencing_meth	solvent	target_gene	target_subfragment
15900.s289.1.S289.1	1.9	not provided	IUF Duesseldorf	TCDD2	326.6	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2577	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9497	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	289.1_S289.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s290.1.S290.1	1.91	not provided	IUF Duesseldorf	TCDD2	626.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2694	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8813	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	290.1_S290.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s291.1.S291.1	1.93	not provided	IUF Duesseldorf	TCDD2	271.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1316	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	5131	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	291.1_S291.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s292.1.S292.1	1.9	not provided	IUF Duesseldorf	TCDD2	447.2	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2043	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9297	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	292.1_S292.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s293.1.S293.1	1.93	not provided	IUF Duesseldorf	TCDD2	323.7	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2755	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8754	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	293.1_S293.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s294.1.S294.1	1.92	not provided	IUF Duesseldorf	TCDD2	575.4	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2647	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8879	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	294.1_S294.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s295.1.S295.1	1.9	not provided	IUF Duesseldorf	TCDD2	374	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1920	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8831	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	295.1_S295.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s296.1.S296.1	1.9	not provided	IUF Duesseldorf	TCDD2	457.9	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2196	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9226	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	296.1_S296.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s297.1.S297.1	1.92	not provided	IUF Duesseldorf	TCDD2	543.4	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2458	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8500	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	297.1_S297.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s298.1.S298.1	1.91	not provided	IUF Duesseldorf	TCDD2	604.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2464	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9654	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	298.1_S298.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s299.1.S299.1	1.9	not provided	IUF Duesseldorf	TCDD2	585.4	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2179	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8793	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	299.1_S299.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s300.1.S300.1	1.9	not provided	IUF Duesseldorf	TCDD2	214.7	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2749	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	11216	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	300.1_S300.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s301.1.S301.1	1.92	not provided	IUF Duesseldorf	TCDD2	550.1	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1702	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7336	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	301.1_S301.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s302.1.S302.1	1.92	not provided	IUF Duesseldorf	TCDD2	600.5	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1553	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	5282	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	302.1_S302.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s303.1.S303.1	1.9	not provided	IUF Duesseldorf	TCDD2	568.5	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1270	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	4869	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	303.1_S303.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s304.1.S304.1	1.92	not provided	IUF Duesseldorf	TCDD2	628.4	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2026	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8604	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	304.1_S304.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s305.1.S305.1	1.91	not provided	IUF Duesseldorf	TCDD2	517.1	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2448	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8393	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	305.1_S305.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s306.1.S306.1	1.92	not provided	IUF Duesseldorf	TCDD2	310.6	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2562	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9631	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	306.1_S306.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s307.1.S307.1	1.92	not provided	IUF Duesseldorf	TCDD2	400.1	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2056	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7212	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	307.1_S307.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s308.1.S308.1	1.9	not provided	IUF Duesseldorf	TCDD2	570.6	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2961	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9723	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	308.1_S308.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s309.1.S309.1	1.92	not provided	IUF Duesseldorf	TCDD2	526.2	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2194	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7947	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	309.1_S309.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s310.1.S310.1	1.91	not provided	IUF Duesseldorf	TCDD2	690.5	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2511	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8963	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	310.1_S310.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s311.1.S311.1	1.94	not provided	IUF Duesseldorf	TCDD2	371.7	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2328	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7971	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	311.1_S311.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s312.1.S312.1	1.89	not provided	IUF Duesseldorf	TCDD2	480.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2624	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8652	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	312.1_S312.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s313.1.S313.1	1.94	not provided	IUF Duesseldorf	TCDD2	625.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1534	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	8215	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	313.1_S313.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s314.1.S314.1	1.92	not provided	IUF Duesseldorf	TCDD2	499.2	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1279	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	6935	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	314.1_S314.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s315.1.S315.1	1.92	not provided	IUF Duesseldorf	TCDD2	374.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1245	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	4884	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	315.1_S315.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s316.1.S316.1	1.91	not provided	IUF Duesseldorf	TCDD2	739.3	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2283	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	9049	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	316.1_S316.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s317.1.S317.1	1.9	not provided	IUF Duesseldorf	TCDD2	323.3	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2098	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7104	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	317.1_S317.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s318.1.S318.1	1.92	not provided	IUF Duesseldorf	TCDD2	627.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1905	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7542	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	318.1_S318.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s319.1.S319.1	1.91	not provided	IUF Duesseldorf	TCDD2	489	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1852	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7701	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	319.1_S319.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s320.1.S320.1	1.9	not provided	IUF Duesseldorf	TCDD2	494.6	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2121	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7404	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	320.1_S320.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s321.1.S321.1	1.9	not provided	IUF Duesseldorf	TCDD2	483.5	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1568	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	5569	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	321.1_S321.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s322.1.S322.1	1.91	not provided	IUF Duesseldorf	TCDD2	515.8	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2290	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	6075	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	322.1_S322.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s323.1.S323.1	1.92	not provided	IUF Duesseldorf	TCDD2	861.9	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2003	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	7749	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	323.1_S323.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s324.1.S324.1	1.91	not provided	IUF Duesseldorf	TCDD2	453.1	timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2328	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	6624	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	324.1_S324.1	Sequencing by synthesis	C6	16S rRNA	V4
15900.s325.1.S325.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2208	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	6337	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	325.1_S325.1	Sequencing by synthesis		16S rRNA	V4
15900.s326.1.S326.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1804	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	5550	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	326.1_S326.1	Sequencing by synthesis		16S rRNA	V4
15900.s327.1.S327.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1782	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	4362	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	327.1_S327.1	Sequencing by synthesis		16S rRNA	V4
15900.s328.1.S328.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1332	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	2408	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	328.1_S328.1	Sequencing by synthesis		16S rRNA	V4
15900.s329.1.S329.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1578	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	2775	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	329.1_S329.1	Sequencing by synthesis		16S rRNA	V4
15900.s330.1.S330.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	1317	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	1863	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	330.1_S330.1	Sequencing by synthesis		16S rRNA	V4
15900.s331.1.S331.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	2592	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	4998	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	331.1_S331.1	Sequencing by synthesis		16S rRNA	V4
15900.s332.1.S332.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	921	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	810	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	332.1_S332.1	Sequencing by synthesis		16S rRNA	V4
15900.s333.1.S333.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK	535	Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	465	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	333.1_S333.1	Sequencing by synthesis		16S rRNA	V4
15900.s334.1.S334.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK		Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	705	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	334.1_S334.1	Sequencing by synthesis		16S rRNA	V4
15900.s335.1.S335.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK		Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	708	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	335.1_S335.1	Sequencing by synthesis		16S rRNA	V4
15900.s336.1.S336.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK		Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	479	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	336.1_S336.1	Sequencing by synthesis		16S rRNA	V4
15900.s337.1.S337.1		not provided	IUF Duesseldorf	TCDD2		timecurse_TCDD_treatment	M05620:119:000000000-DLGNK		Illumina MiSeq	DNA of cecal and fecal samples were extracted using QIAamp PowerFecal DNA Kit (QIAGEN) according to manufacturers instructions and sequenced for the V4 region of the 16S rRNA amplicon, performed with Illumina MiSeq technique. The 16S rRNA sequencing targeting the V4 region was performed using the Illumina MiSeq Reagent Kit (Illumina, MS102-2001). For amplicon sequencing the libraries were prepared following the Illumina 16S Library preparation protocol, amplifying the variable V4 regions of 16S rRNA (FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT) and using Illumina TruSeq HT Kits i5 and i7 barcodes. Sequencing was performed in single-end at 285 bp in the Illumina MiSeq using a v2 cassette, 30 percent DNA of PhiX was added to the library to avoid low complexity sequencing issues.	GT	645	FWD: GTGYCAGCMGCCGCGGTAA; REV: GGACTACNVGGGTWTCTAAT	Illumina	GTGYCAGCMGCCGCGGTAA	18069	Illumina Inc	not provided	337.1_S337.1	Sequencing by synthesis		16S rRNA	V4
